Factors Affecting Treatment Response and Unique Case of Ossified Intramuscular Hemangioma

Ikuo Kudawara

Department of Dermatology and Venerology, Ibn Rochd University Hospital of Casablanca, Morocco

Published Date: 2023-06-08
DOI10.36648/ipsdsc.8.2.84

Ikuo Kudawara*

Department of Dermatology and Venerology, Ibn Rochd University Hospital of Casablanca, Morocco

*Corresponding Author:
Ikuo Kudawara
Department of Dermatology and Venerology,
Ibn Rochd University Hospital of Casablanca,
Morocco,
E-mail: Kudwara.i@uhc.ma

Received date: May 08, 2023 Manuscript No. IPSDSC-23-17147; Editor assigned date: May 10, 2023, PreQC No. IPSDSC-23-17147 (PQ); Reviewed date: May 22, 2023, QC No. IPSDSC-23-17147; Revised date: June 01, 2023, Manuscript No. IPSDSC-23-17147 (R); Published date: June 08, 2023, DOI: 10.36648/ipsdsc.8.2.84

Citation: Kudawara I (2023) Factors Affecting Treatment Response and Unique Case of Ossified Intramuscular Hemangioma. Skin Dis Skin Care: Vol. 8 No.2:84

Visit for more related articles at Skin Diseases & Skin Care

Description

The most prevalent vascular tumor in children is Infantile Hemangioma (IH); 4 to 10% of infants are affected. Although the exact cause is still unknown, certain risk factors, such as low birth weight, female sex, prematurity, White race, and a history of IH in the family, are linked to the development of IH. When systemic therapy is required, propranolol has become the firstline treatment since the first case report of an IH responding to it in 2008. Although propranolol-resistant IHs is uncommon, their incidence has been estimated to be less than one percent in the published literature. Clinical risk factors for treatment failure, on the other hand, are not well understood. Our study's objective was to investigate the factors that could predict IH's poor response to propranolol treatment.

It is difficult to tell the difference between infantile and congenital hemangiomas, but it is necessary for the right treatment. The immunohistochemical marker glucose carrier type 1 is useful, yet biopsies are phenomenal here. This retrospective study sought to compare and describe the epidemiological, clinical, and treatment characteristics of congenital and infantile hemangiomas discovered at a tertiary care hospital over a three-year period. 107 hemangiomas were studied: 70 infantile hemangiomas, 34 congenital hemangiomas (rapidly involuting, partially involuting, and noninvoluting), and 3 hemangiomas awaiting classification are included. The most common tumors were superficial infantile hemangiomas of the head and neck. Inherent hemangiomas were most frequently situated on the storage compartment. Patients with infantile hemangiomas were more likely to have the studied risk factors. Treatment response was unaffected by sex, in vitro fertilization, lesion depth and location, or treatment type in this group of patients.

Vascular Laser Treatment

During the time period being evaluated, there were no serious adverse effects reported. A girl with an ulcerated gluteal hemangioma required both vascular laser treatment and lowdose propranolol (1.5 mg/kg/d) to achieve a satisfactory cosmetic result. Following a total cardiology assessment, the 2 patients with PHACE condition were treated with propranolol 1 mg/kg/d; Up to a maximum of 2 mg/kg/d, the dosages were increased more slowly than usual. Treatment response was not significantly influenced by sex, tumor depth, anatomic location, conception via IVF or not, or treatment (supplementary material).

Both infantile and congenital hemangiomas were more prevalent in girls. For infantile and congenital hemangiomas that do not involute, but not for rapidly or partially involuting hemangiomas, where sex-related differences have typically not been observed, this female predominance has been described. Both congenital and infantile hemangiomas were more likely to have an exclusively superficial component, while congenital hemangiomas were more likely to have an exclusively deep component (14% versus 4%). For infantile hemangiomas, the head and neck (42.8%) and the lower extremities/perineum (32.3%) were the most common locations. This subsequent finding appears differently in relation to past reports showing that most hemangiomas, both intrinsic and juvenile, are situated on the head and neck. Mean age at the first visit was comparative in quite a while, yet time to symptomatic affirmation was 1.3 (0.1) months longer in patients with intrinsic hemangiomas. Possibly because we used a clearance rate of 80% to 100% to define complete response and because patients in routine clinical settings are given the treatment they think is best instead of being assigned to a treatment at random. Treatment response was unaffected by sex, location, whether or not IVF was used, the type of treatment, or the depth of the tumor. In contrast, previous research has shown that superficial hemangiomas respond better.

For the purpose of surgical planning, we chose the endoscopic endonasal transsphenoidal approach to the cavernous sinus, which was revealed in our literature review and has seen increased use in recent years. The endoscopic endonasal approach is safer than other transcranial and microscopic transsphenoidal approaches because it gives a wider view of the medial wall. When treating a capillary hemangioma in the cavernous sinus, both transcranial and endoscopic options should be considered. Endoscopic procedures, on the other hand, typically perform better than transcranial ones in centers with a skilled skull base team. It is essential to keep in mind that radiotherapy may be used as a complement to surgery if the tumor adheres to vital neurological and vascular structures.

Treating Capillary Hemangioma

There are a number of things to take into consideration when selecting the method of treatment for these patients. Even though radiotherapy is very good at treating capillary hemangioma, surgery is usually preferred, especially for patients who are symptomatic. For those unfit to go through a medical procedure, radiotherapy stays a significant therapy choice, despite the fact that it’s drawn out results are yet to be completely perceived.

Between January 2014 and January 2022, a prospective observational cohort study was carried out at the Department of Dermatology and Venereology in Casablanca, Morocco. This longitudinal study's primary objective was to examine the factors that predict poor propranolol therapy response in IH. A 25-year-old woman presented with persistent soft tissue swelling and chronic pain in the left thigh for three months prior to diagnosis. We included all patients with IH who received oral propranolol therapy at a dosage of 2–3 mg/kg/day divided into two daily doses. She gave birth to her first child the year before, and the symptoms were unrelated to any relevant past, including trauma. The soft tissue mass was palpable with unclear margins during physical examination. It was immobile and lacked tenderness in the left lateral thigh. A plain X-ray of the left femur revealed ossification of the soft tissue and thickening of the lateral cortex in the diaphysis. A gradual continuum of cartilage transformation into bone is observed. The outermost layer makes it easy to see the vessels. An extremely uncommon case of ossified intramuscular hemangioma with thigh cartilage formation is described in this report. The incisional biopsy's histology revealed the development of peripheral cartilage, central woven and lamellar bone with fatty marrow, and vascular tissue surrounding the mass. This is the first case to show how an intramuscular hemangioma's enchondral ossification progresses from its infancy to its near-maturity.

open access journals, open access scientific research publisher, open access publisher
Select your language of interest to view the total content in your interested language

Viewing options

Flyer image

Share This Article

paper.io

agar io

wowcappadocia.com
cappadocia-hotels.com
caruscappadocia.com
brothersballoon.com
balloon-rides.net

wormax io